Paolo Martelletti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Sezione 18 - Dolore in medicina interna	SIMI HANDBOOK. Terapia medica	2018
Pharmacogenetic considerations for migraine therapies	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY	2018
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache	PAIN PRACTICE	2017
Lasmiditan for the treatment of migraine	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2017
Tackling the perils of unawareness. the cluster headache case	THE JOURNAL OF HEADACHE AND PAIN	2017
Acute treatment of migraine: quo vadis?	EXPERT OPINION ON PHARMACOTHERAPY	2017
The changing comet	THE JOURNAL OF HEADACHE AND PAIN	2017
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers	THE JOURNAL OF HEADACHE AND PAIN	2017
A critical evaluation on MOH current treatments	CURRENT TREATMENT OPTIONS IN NEUROLOGY	2017
Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine. Repose study methodology and baseline data	THE JOURNAL OF HEADACHE AND PAIN	2017
Hormonal contraceptives and risk of ischemic stroke in women with migraine. a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)	THE JOURNAL OF HEADACHE AND PAIN	2017
The application of CGRP(r) monoclonal antibodies in migraine spectrum: needs and priorities	BIODRUGS	2017
Long-term treatment benefits and prolonged efficacy of OnabotulinumtoxinA in patients affected by chronic migraine and medication overuse headache over 3 years of therapy	FRONTIERS IN NEUROLOGY	2017
Calcitonin Gene-Related peptide receptor as a novel target for the management of people with episodic migraine. Current evidence and safety profile of erenumab	JOURNAL OF PAIN RESEARCH	2017
Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine. a prospective, open-label, exploratory study	EUROPEAN JOURNAL OF PAIN	2016
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY	2016
Greater occipital nerve as target for refractory chronic headaches. from corticosteroid block to invasive neurostimulation and back	EXPERT REVIEW NEUROTHERAPEUTICS	2016
Altered serum levels of kynurenine metabolites in patients affected by cluster headache	THE JOURNAL OF HEADACHE AND PAIN	2016
Altered kynurenine pathway metabolites in serum of chronic migraine patients	THE JOURNAL OF HEADACHE AND PAIN	2016
Impact of migraine on fibromyalgia symptoms	THE JOURNAL OF HEADACHE AND PAIN	2016